enVVeno Medical Corporation (NVNO) investor relations documents from the company's IR site: 1 presentation, 2 press releases; latest deck 2026-07-10. Read in-app with summaries. First-party data.
View Presentation — enVVeno Medical's enVVe System offers a transcatheter solution for Deep Venous Insufficiency, targeting a $20B market with FDA alignment and significant revenue potential.
| Published | Type | Document |
|---|---|---|
| 2026-07-10 | Presentation | View Presentation |
| 2026-03-27 | Press release | enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe® System |
| Press release | enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class |
NVNO overview · NVNO earnings · NVNO financials · NVNO KPIs · NVNO ownership · NVNO peers · NVNO filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.